Forward Citations = 175

Loading Chart...

3 inventors (with patents filed for the assignee):

Gholam A Peyman (4 out of 232 patents)

Stephen A Updegraff (2 out of 2 patents)

Paolo Arpa (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 5928663 - Intraocular perfluorcarbon compositions and surgical methods of using (1999-07-27),

2. 5560356 - Diagnostic system and method using an implanted reflective device (1996-10-01),

3. 5405355 - Method of radial keratotomy employing a vibrating cutting blade (1995-04-11),

4. 5374272 - Apparatus and method for mechanically dilating the pupil of an eye (1994-12-20),

Company Overview

Vitrophage, Inc. is a biotechnology company specializing in developing innovative solutions for the treatment of viral infections. Our proprietary technology leverages the natural abilities of bacteriophages to target and destroy harmful viruses. With a focus on research and development, Vitrophage aims to revolutionize the field of antiviral therapies by offering safe and effective treatments for a wide range of viruses.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#5 in Lyons, IL

#2,840 in Illinois

#60,641 in US

Lyons, IL, United States of America

Vitrophage, Inc.

Forward Citations = 175

3 inventors:

Gholam A Peyman (4 out of 232 patents)

Stephen A Updegraff (2 out of 2 patents)

Paolo Arpa (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vitrophage, Inc.. Retrieved from https://idiyas.com/company/vitrophage

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]